Pegylated Liposomal Doxorubicin, Vincristine, and Reduced-Dose Dexamethasone as First-Line Therapy for Multiple Myeloma (Q35558330)
Jump to navigation
Jump to search
scientific article published on August 1, 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Pegylated Liposomal Doxorubicin, Vincristine, and Reduced-Dose Dexamethasone as First-Line Therapy for Multiple Myeloma |
scientific article published on August 1, 2003 |
Statements
Pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone as first-line therapy for multiple myeloma (English)
Pegylated Liposomal Doxorubicin, Vincristine, and Reduced-Dose Dexamethasone as First-Line Therapy for Multiple Myeloma (English)
1 reference
Mohamad Hussein
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference